학술논문

Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial
Document Type
Article
Source
In: Gastro Hep Advances. (Gastro Hep Advances, January 2024, 3(3):417-425)
Subject
Language
English
ISSN
27725723